Home » Topics » Regulatory » EMA

EMA
RSS

European Commission grants orphan designation to Vertex's cystic fibrosis candidate

Aug. 18, 2010

EMA validates CTI's expanded pediatric program for pixantrone in NHL

Aug. 16, 2010

Dexamethasone intravitreal implant receives E.U. orphan drug status for noninfectious uveitis

Aug. 16, 2010

MK-4827 receives E.U. orphan drug status in ovarian cancer

Aug. 16, 2010

European Commission grants orphan status to bosutinib in CML

Aug. 13, 2010

Tranilast obtains orphan drug status for prevention of scarring in glaucoma surgery

Aug. 10, 2010

HBGF-1-coated biodegradable device receives E.U. orphan drug status for spinal cord injury

Aug. 10, 2010

EMA grants octenidine orphan drug status for sepsis in premature infants

Aug. 10, 2010

Obeticholic acid receives E.U. orphan drug status for primary biliary cirrhosis

Aug. 10, 2010

Celgene's pomalidomide receives E.U. orphan drug status for myelofibrosis

Aug. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...